NCT05804084View on ClinicalTrials.gov

Patient-centered and Neurocognitive Outcomes with Acetazolamide for Sleep Apnea

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 16, 2023

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Obstructive Sleep Apnea
Interventions
DRUG

Acetazolamide

Acetazolamide tablet (encapsulated)

DRUG

Placebo

Sugar capsule manufactured to match encapsulated Acetazolamide

Trial Locations (1)

92121

RECRUITING

UC San Diego; Altman Clinical and Translational Research Institute Building, La Jolla

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of California, San Diego

OTHER